Voloridge Investment Management, LLC Black Diamond Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.66 - $5.61 $118,319 - $249,538
-44,481 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$5.18 - $8.48 $481,532 - $788,300
-92,960 Reduced 67.64%
44,481 $237,000
Q3 2021

Nov 15, 2021
BUY
$8.46 - $12.42 $94,616 - $138,905
11,184 Added 8.86%
137,441 $1.16 Million
Q2 2021

Aug 16, 2021
BUY
$12.19 - $28.17 $1.54 Million - $3.56 Million
126,257 New
126,257 $1.54 Million

Others Institutions Holding BDTX

# of Institutions
121
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $89.4M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email